NCT00074399View on ClinicalTrials.gov

Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV

PHASE3CompletedINTERVENTIONAL
Enrollment

775

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
HIV Infections
Interventions
DRUG

Nevirapine

Tablet taken orally daily. Dosage depends on age and body surface area

DRUG

Nevirapine placebo

Placebo tablet taken orally daily

Trial Locations (1)

Unknown

Tikur Anbessa Hospital, Addis Ababa

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00074399 - Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV | Biotech Hunter | Biotech Hunter